These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 9924810)
21. Stimulation of megakaryocytopoiesis in mice by human modified C-reactive protein (mCRP). Potempa LA; Motie M; Wright KE; Crump BL; Radosevich JA; Sakai N; Lai G; Tanaka K; Kojima E; Tsuboi A Exp Hematol; 1996 Feb; 24(2):258-64. PubMed ID: 8641350 [TBL] [Abstract][Full Text] [Related]
22. Solubilization and purification of recombinant modified C-reactive protein from inclusion bodies using reversible anhydride modification. Potempa LA; Yao ZY; Ji SR; Filep JG; Wu Y Biophys Rep; 2015; 1():18-33. PubMed ID: 26942216 [TBL] [Abstract][Full Text] [Related]
23. Acidic pH promotes oxidation-induced dissociation of C-reactive protein. Li SL; Feng JR; Zhou HH; Zhang CM; Lv GB; Tan YB; Ge ZB; Wang MY Mol Immunol; 2018 Dec; 104():47-53. PubMed ID: 30408622 [TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical localization of modified C-reactive protein antigen in normal vascular tissue. Diehl EE; Haines GK; Radosevich JA; Potempa LA Am J Med Sci; 2000 Feb; 319(2):79-83. PubMed ID: 10698090 [TBL] [Abstract][Full Text] [Related]
25. A role for monomeric C-reactive protein in regulation of angiogenesis, endothelial cell inflammation and thrombus formation in cardiovascular/cerebrovascular disease? Slevin M; Krupinski J Histol Histopathol; 2009 Nov; 24(11):1473-8. PubMed ID: 19760596 [TBL] [Abstract][Full Text] [Related]
26. Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions. Ji SR; Wu Y; Potempa LA; Liang YH; Zhao J Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):935-41. PubMed ID: 16456095 [TBL] [Abstract][Full Text] [Related]
27. Opposing effects of C-reactive protein isoforms on shear-induced neutrophil-platelet adhesion and neutrophil aggregation in whole blood. Khreiss T; József L; Potempa LA; Filep JG Circulation; 2004 Oct; 110(17):2713-20. PubMed ID: 15492312 [TBL] [Abstract][Full Text] [Related]
28. Current Position on the Role of Monomeric C-reactive Protein in Vascular Pathology and Atherothrombosis. Melnikov IS; Kozlov SG; Saburova OS; Avtaeva YN; Prokofieva LV; Gabbasov ZA Curr Pharm Des; 2020; 26(1):37-43. PubMed ID: 31840602 [TBL] [Abstract][Full Text] [Related]
29. A biofunctional review of C-reactive protein (CRP) as a mediator of inflammatory and immune responses: differentiating pentameric and modified CRP isoform effects. Olson ME; Hornick MG; Stefanski A; Albanna HR; Gjoni A; Hall GD; Hart PC; Rajab IM; Potempa LA Front Immunol; 2023; 14():1264383. PubMed ID: 37781355 [TBL] [Abstract][Full Text] [Related]
30. A redox sensitivity-based method to quantify both pentameric and monomeric C-reactive protein in a single assay. Yao Z; Zhang Y; Potempa LA; Rajab I; Ji L; Lv J; Liu S; Zhang L; Wu H J Immunol Methods; 2019 Jul; 470():40-45. PubMed ID: 31034879 [TBL] [Abstract][Full Text] [Related]
31. Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy. Thiele JR; Habersberger J; Braig D; Schmidt Y; Goerendt K; Maurer V; Bannasch H; Scheichl A; Woollard KJ; von Dobschütz E; Kolodgie F; Virmani R; Stark GB; Peter K; Eisenhardt SU Circulation; 2014 Jul; 130(1):35-50. PubMed ID: 24982116 [TBL] [Abstract][Full Text] [Related]
32. Functionality of C-Reactive Protein for Atheroprotection. Singh SK; Agrawal A Front Immunol; 2019; 10():1655. PubMed ID: 31379851 [TBL] [Abstract][Full Text] [Related]
33. Monomeric C-reactive protein activates endothelial cells via interaction with lipid raft microdomains. Ji SR; Ma L; Bai CJ; Shi JM; Li HY; Potempa LA; Filep JG; Zhao J; Wu Y FASEB J; 2009 Jun; 23(6):1806-16. PubMed ID: 19136614 [TBL] [Abstract][Full Text] [Related]
34. In vitro generation and bioactivity evaluation of C-reactive protein intermediate. Lv JM; Wang MY PLoS One; 2018; 13(5):e0198375. PubMed ID: 29851992 [TBL] [Abstract][Full Text] [Related]
35. A conformational change of C-reactive protein in burn wounds unmasks its proinflammatory properties. Braig D; Kaiser B; Thiele JR; Bannasch H; Peter K; Stark GB; Koch HG; Eisenhardt SU Int Immunol; 2014 Aug; 26(8):467-78. PubMed ID: 24844702 [TBL] [Abstract][Full Text] [Related]
36. Biodistribution and clearance of 125I-labeled C-reactive protein and 125I-labeled modified C-reactive protein in CD-1 mice. Motie M; Schaul KW; Potempa LA Drug Metab Dispos; 1998 Oct; 26(10):977-81. PubMed ID: 9763402 [TBL] [Abstract][Full Text] [Related]
37. Binding of model soluble immune complexes to modified C-reactive protein. Motie M; Brockmeier S; Potempa LA J Immunol; 1996 Jun; 156(11):4435-41. PubMed ID: 8666818 [TBL] [Abstract][Full Text] [Related]
38. Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils. Khreiss T; József L; Potempa LA; Filep JG Circ Res; 2005 Sep; 97(7):690-7. PubMed ID: 16123332 [TBL] [Abstract][Full Text] [Related]
39. Analysis of the physicochemical state of C-reactive protein in different preparations including 2 certified reference materials. Rzychon M; Zegers I; Schimmel H Clin Chem; 2010 Sep; 56(9):1475-82. PubMed ID: 20624850 [TBL] [Abstract][Full Text] [Related]
40. Monomeric C-reactive protein regulates fibronectin mediated monocyte adhesion. Ullah N; Ma FR; Han J; Liu XL; Fu Y; Liu YT; Liang YL; Ouyang H; Li HY Mol Immunol; 2020 Jan; 117():122-130. PubMed ID: 31765841 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]